{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T10:54:08Z","timestamp":1758279248104},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,7]]},"DOI":"10.7759\/cureus.57791","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:39:43Z","timestamp":1712551183000},"source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Assessment of Cardiac Function in Breast Cancer Patients: Integrating Multiparametric Speckle Tracking Imaging and Conventional Echocardiography Parameters"],"prefix":"10.7759","author":[{"given":"Marina","family":"Leitman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmuel","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oran","family":"Tzuman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotem","family":"Merose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Shimoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC)","volume":"43","author":"Lyon AR","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, et al.. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J. 2022, 43:4229-361. 10.1093\/eurheartj\/ehac244","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.06.003","article-title":"Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient","volume":"11","author":"Plana JC","year":"2018","unstructured":"Plana JC, Thavendiranathan P, Bucciarelli-Ducci C, Lancellotti P. Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient. JACC Cardiovasc Imaging. 2018, 11:1173-86. 10.1016\/j.jcmg.2018.06.003","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan P","year":"2013","unstructured":"Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovi\u0107 ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol. 2013, 61:77-84. 10.1016\/j.jacc.2012.09.035","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.11.063","article-title":"The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy","volume":"57","author":"Fallah-Rad N","year":"2011","unstructured":"Fallah-Rad N, Walker JR, Wassef A, et al.. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011, 57:2263-70. 10.1016\/j.jacc.2010.11.063","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jer187","article-title":"Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy","volume":"12","author":"Stoodley PW","year":"2011","unstructured":"Stoodley PW, Richards DA, Hui R, et al.. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. Eur J Echocardiogr. 2011, 12:945-52. 10.1093\/ejechocard\/jer187","journal-title":"Eur J Echocardiogr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya H","year":"2012","unstructured":"Sawaya H, Sebag IA, Plana JC, et al.. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012, 5:596-603. 10.1161\/CIRCIMAGING.112.973321","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jer172","article-title":"Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy","volume":"13","author":"Motoki H","year":"2012","unstructured":"Motoki H, Koyama J, Nakazawa H, et al.. Torsion analysis in the early detection of anthracycline-mediated cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2012, 13:95-103. 10.1093\/ejechocard\/jer172","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref8","article-title":"Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy","volume":"62","author":"Mason JW","year":"1978","unstructured":"Mason JW, Bristow MR, Billingham ME, Daniels JR. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep. 1978, 62:857-64.","journal-title":"Cancer Treat Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski LG","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, et al.. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010, 23:685-713. 10.1016\/j.echo.2010.05.010","journal-title":"J Am Soc Echocardiogr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.027516","article-title":"Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function","volume":"90","author":"Dorup I","year":"2004","unstructured":"Dorup I, Levitt G, Sullivan I, Sorensen K. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function. Heart. 2004, 90:1214-6. 10.1136\/hrt.2003.027516","journal-title":"Heart"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90138-d","article-title":"Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans","volume":"20","author":"Stoddard MF","year":"1992","unstructured":"Stoddard MF, Seeger J, Liddell NE, Hadley TJ, Sullivan DM, Kupersmith J. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol. 1992, 20:62-9. 10.1016\/0735-1097(92)90138-d","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7133.2011.00278.x","article-title":"Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the AIDA protocol","volume":"18","author":"Pellicori P","year":"2012","unstructured":"Pellicori P, Calicchia A, Lococo F, Cimino G, Torromeo C. Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the AIDA protocol. Congest Heart Fail. 2012, 18:217-21. 10.1111\/j.1751-7133.2011.00278.x","journal-title":"Congest Heart Fail"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.173997","article-title":"Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study","volume":"96","author":"Ho E","year":"2010","unstructured":"Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ, Murphy RT. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart. 2010, 96:701-7. 10.1136\/hrt.2009.173997","journal-title":"Heart"},{"key":"ref14","article-title":"Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI","volume":"53","author":"Nagy AC","year":"2006","unstructured":"Nagy AC, Tolnay E, Nagyk\u00e1lnai T, Forster T. Cardiotoxicity of anthracycline in young breast cancer female patients: the possibility of detection of early cardiotoxicity by TDI. Neoplasma. 2006, 53:511-7.","journal-title":"Neoplasma"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-008-9013-4","article-title":"Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study","volume":"14","author":"Nagy AC","year":"2008","unstructured":"Nagy AC, Cser\u00e9p Z, Tolnay E, Nagyk\u00e1lnai T, Forster T. Early diagnosis of chemotherapy-induced cardiomyopathy: a prospective tissue Doppler imaging study. Pathol Oncol Res. 2008, 14:69-77. 10.1007\/s12253-008-9013-4","journal-title":"Pathol Oncol Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(01)01476-x","article-title":"Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children","volume":"9","author":"Eidem BW","year":"2001","unstructured":"Eidem BW, Sapp BG, Suarez CR, Cetta F. Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol. 2001, 9:1120-2. 10.1016\/s0002-9149(01)01476-x","journal-title":"Am J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(00)01222-4","article-title":"Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy","volume":"11","author":"Ishii M","year":"2000","unstructured":"Ishii M, Tsutsumi T, Himeno W, et al.. Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy. Am J Cardiol. 2000, 11:10.1016\/s0002-9149(00)01222-4","journal-title":"Am J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-006-9145-0","article-title":"Tei index in adult patients submitted to adriamycin chemotherapy: failure to predict early systolic dysfunction. Diagnosis of adriamycin cardiotoxicity","volume":"23","author":"Rohde LE","year":"2007","unstructured":"Rohde LE, Baldi A, Weber C, et al.. Tei index in adult patients submitted to adriamycin chemotherapy: failure to predict early systolic dysfunction. Diagnosis of adriamycin cardiotoxicity. Int J Cardiovasc Imaging. 2007, 23:185-91. 10.1007\/s10554-006-9145-0","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev354","article-title":"EACVI\/EHRA expert consensus document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation","volume":"17","author":"Donal E","year":"2016","unstructured":"Donal E, Lip GY, Galderisi M, et al.. EACVI\/EHRA expert consensus document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Eur Heart J Cardiovasc Imaging. 2016, 17:355-83. 10.1093\/ehjci\/jev354","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.770580","article-title":"Assessment of myocardial work in cancer therapy-related cardiac dysfunction and analysis of CTRCD prediction by echocardiography","volume":"12","author":"Guan J","year":"2021","unstructured":"Guan J, Bao W, Xu Y, et al.. Assessment of myocardial work in cancer therapy-related cardiac dysfunction and analysis of CTRCD prediction by echocardiography. Front Pharmacol. 2021, 12:10.3389\/fphar.2021.770580","journal-title":"Front Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19052826","article-title":"Myocardial work brings new insights into left ventricular remodelling in cardio-oncology patients","volume":"19","author":"Vaz Ferreira V","year":"2022","unstructured":"Vaz Ferreira V, Mano TB, Cardoso I, et al.. Myocardial work brings new insights into left ventricular remodelling in cardio-oncology patients. Int J Environ Res Public Health. 2022, 19:2826. 10.3390\/ijerph19052826","journal-title":"Int J Environ Res Public Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2022.02.027","article-title":"Diagnostic and prognostic value of myocardial work indices for identification of cancer therapy-related cardiotoxicity","volume":"15","author":"Calvillo-Arg\u00fcelles O","year":"2022","unstructured":"Calvillo-Arg\u00fcelles O, Thampinathan B, Somerset E, et al.. Diagnostic and prognostic value of myocardial work indices for identification of cancer therapy-related cardiotoxicity. JACC Cardiovasc Imaging. 2022, 15:1361-76. 10.1016\/j.jcmg.2022.02.027","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/239350-comprehensive-assessment-of-cardiac-function-in-breast-cancer-patients-integrating-multiparametric-speckle-tracking-imaging-and-conventional-echocardiography-parameters","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:39:47Z","timestamp":1712551187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/239350-comprehensive-assessment-of-cardiac-function-in-breast-cancer-patients-integrating-multiparametric-speckle-tracking-imaging-and-conventional-echocardiography-parameters"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,7]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.57791","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,7]]}}}